Anomalies of asymmetry of clinical signs in Parkinsonism

Movement Disorders

Volumn 19, Issue 2, 2004, Pages 151-157

  Toth, Cory ^a,b   Rajput, Michelle ^a   Rajput, Ali H ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Asymmetry; Bradykinesia; Clinical features; Parkinson's disease; Rigidity; Tremor

Indexed keywords

ADULT; AGED; ARM DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HUMAN; IDIOPATHIC DISEASE; LEG DISEASE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PARKINSON DISEASE; PRIORITY JOURNAL; REST; RETROSPECTIVE STUDY; REVIEW; TOPOGRAPHY; TREMOR;

ACTIVITIES OF DAILY LIVING; AGED; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FUNCTIONAL LATERALITY; HUMANS; HYPOKINESIA; MALE; MIDDLE AGED; MUSCLE RIGIDITY; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; RETROSPECTIVE STUDIES; TREMOR;

EID: 1542300952     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10685     Document Type: Review

References (34)

1. Rajput AH, Pahwa R, Pahwa P, Rajput A. Prognostic significance of the onset mode in parkinsonism. Neurology 1993;43:829-830.
2. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992;42:1142-1146.
3. Lee CS, Schulzer M, Mak E, Hammerstad JP, Calne S, Calne DB. Patterns of asymmetry do not change over the course of idiopathic parkinsonism: implications for pathogenesis. Neurology 1995;45: 435-439.
4. Rajput AH. Parkinsonism, aging, and gait apraxia. In: Stern MB, Koller WC, editors. Parkinsonian syndromes. New York: Marcel Dekker; 1993. p 511-532.
5. Webster DD. Critical analysis of disability in Parkinson's disease. In: Modern treatment. Vol. 5, no. 2. New York: Harper and Row; 1968. p 257-282.
6. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-442.
7. Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease. Vol. 2. Florham Park, NJ: Macmillan Health Care Information; 1987.
8. Duvoisin RC, Golbe LI. Toward a definition of Parkinson's disease. Neurology 1989;39:746.
9. Eberling JL, Pivirotto P, Bringas J, Bankiewicz KS. Tremor is associated with PET measures of nigrostriatal dopamine function in MPTP-lesioned monkeys. Exp Neurol 2000;165:342-346.
10. Pechadre JC, Larochelle L, Poirier LJ. Parkinsonian akinesia, rigidity and tremor in the monkey. J Neurol Sci 1976;28:147-157.
11. Jellinger KA. Post mortem studies in Parkinson's disease - is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl 1999;56:1-29.
12. Kassubek J, Juengling FD, Hellwig B, Knauff M, Spreer J, Lucking CH Hypermetabolism in the ventrolateral thalamus in unilateral parkinsonian resting tremor: a positron emission tomography study. Neurosci Lett 2001;304:17-20.
13. Kassubek J, Juengling FD, Hellwig B, Spreer J, Lucking CH. Thalamic gray matter changes in unilateral parkinsonian resting tremor: a voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging. Neurosci Lett 2002;323:29-32.15.
14. Findley LJ, Gresty MA. Tremor and rhythmical involuntary movements in Parkinson's disease. In: Findley LJ, Capilden R, editors. Movement disorders: tremors. New York: Oxford University Press; 1984. p 183-194.
15. Jankovic J, Schwartz KS, Ondo W. Re-emergent tremor of Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;67:646-650.
16. Hömberg V, Hefter H, Reiners K, Freund HJ. Differential effects of changes in mechanical limb properties on physiological and pathological tremor. J Neurol Neurosurg Psychiatry 1987;50:568-579.
17. Hunker CJ, Abbs JH. Uniform frequency of parkinsonian resting tremor in the lips, jaw, tongue, and index finger. Mov Disord 1990;5:71-77.
18. Rajput AH, Rozdilsky B, Ang L, Rajput A. Significance of parkinsonian manifestations inessential tremor. Can J Neurol Sci 1993;20:114-117.
19. Rajput AH, Hornykiewicz O, Deng Y, Birdi S, Miyashita H, Macaulay R. Increased noradrenaline levels in essential tremor brain [abstract S37.003]. American Academy of Neurology 53rd meeting, Philadelphia, 2001.
20. Asenbaum S, Pirker W, Angelberger P, Bencsits G, Pruckmayer M, Brucke T. [123I]beta-CIT and SPECT in essential tremor and Parkinson's disease. J Neural Transm 1998;105:1213-1228.
21. Delwaide PJ, Gonce M. Pathophysiology of Parkinson's signs. In: Jankovic J, Tolosa E, editors. Parkinson's disease and movement disorders. Baltimore: Williams and Wilkins; 1993.
22. Foerster O. Zur analyse und Pathophysiologie der striaten Bewegungstorungen. Z Neurol Psychiatrie 1921;73:1-169.
23. Graybiel AM, Aosaki T, Flaherty AW, Kimura N. The basal ganglia and adaptive motor control. Science 1994;265:1826-1831.
24. Shinotoh H, Uchida Y, Ito H, Harrori T. Relationship between striatal [123I]beta-CIT binding and four major clinical signs in Parkinson's disease. Ann Nucl Med 2000;14:199-203.
25. Ghaemi M, Raethjen J, Hilker R, Rudolf J, Sobesky J, Deuschl G, Heiss WD. Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic study. Mov Disord 2002;17:782-788.
26. Winogrodzka A, Wagenaar RC, Bergmans P, et al. Rigidity decreases resting tremor intensity in Parkinson's disease: a [(123)I]beta-CIT SPECT study in early, nonmedicated patients. Mov Disord 2001;16:1033-1040.
27. Piccini P, Weeks RA, Brooks DJ. Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias. Ann Neurol 1997;42:720-726.
28. Vingerhoets FJ, Snow BJ, Lee CS, Schulzer M, Mak E, Calne DB. Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism. Ann Neurol 1994;36: 759-764.
29. Morrish PK, Sawle GV, Brooks DJ. An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain 1996;119:585-591.
30. Morrish PK, Rakshi JS, Bailey DL, Sawle GV, Brooks DJ. Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET. J Neurol Neurosurg Psychiatry 1998;64:314-319.
31. Morrish PK, Sawle GV, Brooks DJ. Clinical and [18F]dopa PET findings in early Parkinson's disease. J Neurol Neurosurg Psychiatry 1995;59:597-600.
32. Wolfson LI, Leenders KL, Brown LL, Jones T. Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease. Neurology 1985;35:1399-1405.
33. Lee CS, Samii A, Sossi V, et al. In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease. Ann Neurol 2000; 47:493-503.
34. Dubinski R, Hallet M. Glucose hypermetabolism of the inferior olive in patients with essential tremor. Ann Neurol 1987;22:118.